Loading insider details...
Beta
Latest Form 4 (Jul 28, 2026): Grant/Award of 47,941 UNCY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 28, 2026 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 47,941 | n/a |
| Jan 13, 2026 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 17,000 | n/a |
| Sep 12, 2025 | Instil Bio, Inc. (TIL) | Exercise/Conversion | 17,000 | $197.2K |
| Jul 30, 2025 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 21,200 | n/a |
| Apr 28, 2025 | Instil Bio, Inc. (TIL) | Grant/Award | 44,851 | n/a |
| Sep 23, 2024 | Instil Bio, Inc. (TIL) | Grant/Award | 45,000 | n/a |
| Jun 11, 2024 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 17,000 | n/a |
| Feb 13, 2024 | Instil Bio, Inc. (TIL) | Grant/Award | 80,000 | n/a |
| Sep 7, 2023 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 189,236 | n/a |
| Jun 28, 2023 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 17,000 | n/a |